Machine learning to predict overall short-term mortality in cutaneous melanoma.
C Cozzolino1, A Buja2, M Rugge3,4
1Soft-Tissue, Peritoneum and Melanoma Surgical Oncology Unit, Veneto Institute of Oncology IOV-IRCCS, Via Gattamelata, 64, 35128, Padua, PD, Italy. claudia.cozzolino@iov.veneto.it.
Artificial intelligence (AI) enhances cutaneous malignant melanoma (CMM) staging by developing a machine learning tool to predict short-term survival. This AI model, utilizing routine clinicopathological data, offers high reliability for improved patient prognosis.
Area of Science:
- Oncology
- Medical Informatics
- Artificial Intelligence
Background:
- Cutaneous malignant melanoma (CMM) is a frequent malignancy where accurate staging is crucial for prognosis.
- Artificial intelligence (AI) is increasingly utilized for developing reliable prognostic staging systems for CMM.
- This study aimed to create a machine learning-based tool for predicting short-term survival in CMM patients.
Purpose of the Study:
- To develop and validate an AI-driven tool for predicting 3-year mortality in cutaneous malignant melanoma (CMM).
- To identify key clinicopathological variables influencing CMM survival beyond current staging systems.
- To deploy the best-performing AI model as an accessible online tool for clinical use.
Main Methods:
- Utilized CMM data from the Veneto Cancer Registry and regional health service.
- Employed univariate Cox regression to assess variable prognostic strength.
- Trained and evaluated multiple machine learning models, including Deep Neural Networks and Random Forests, using cross-validation and hyperparameter optimization.
- Assessed model performance using balanced accuracy, precision, recall, and F1 score on a separate test set.
Main Results:
- Univariate analysis confirmed the prognostic value of TNM staging and identified additional significant variables (sex, tumor site, histotype, growth phase, age).
- The Neural Network and Random Forest models demonstrated superior prognostic performance, achieving balanced accuracies of 91% and 88%, respectively.
- Key predictors of survival included age, T and M stages, mitotic count, and ulceration, as indicated by Gini importance scores.
Conclusions:
- An AI algorithm with high staging reliability for CMM was developed using routinely collected clinicopathological data.
- A web-based tool implementing this AI algorithm is available (unipd.link/melanomaprediction).
- The tool's minimal implementation requirements facilitate its testing and validation in clinical practice for enhanced patient management.
More Related Videos
07:13Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
Published on: April 18, 2025
07:15Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model
Published on: August 16, 2020
Related Concept Videos
Kaplan-Meier Approach
Cancer Survival Analysis
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
